October 1, 2024
New Treatment Options for Patients With Oncogene-Addicted Non–Small Cell Lung Cancer Focusing on EGFR-Mutant Tumors
New therapies for EGFR-mutant lung cancer boost survival rates. Researchers combat drug resistance and aim for tailored treatments to enhance patient care and quality of life.
ASCO Educational Book